Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.94 - $4.61 $369,453 - $877,928
190,440 Added 33.27%
762,799 $2.94 Million
Q1 2024

May 15, 2024

SELL
$1.99 - $5.64 $2.36 Million - $6.7 Million
-1,187,775 Reduced 67.48%
572,359 $1.27 Million
Q4 2023

Feb 14, 2024

SELL
$3.07 - $10.25 $1.99 Million - $6.65 Million
-648,296 Reduced 26.92%
1,760,134 $9.52 Million
Q3 2023

Nov 14, 2023

SELL
$10.52 - $20.68 $7.55 Million - $14.8 Million
-717,456 Reduced 22.95%
2,408,430 $26.2 Million
Q2 2023

Aug 14, 2023

BUY
$17.18 - $23.76 $3.76 Million - $5.21 Million
219,127 Added 7.54%
3,125,886 $68.4 Million
Q1 2023

May 15, 2023

BUY
$18.25 - $30.26 $1.15 Million - $1.91 Million
63,080 Added 2.22%
2,906,759 $53.5 Million
Q4 2022

Feb 14, 2023

BUY
$12.36 - $26.41 $5.27 Million - $11.3 Million
426,223 Added 17.63%
2,843,679 $73.4 Million
Q3 2022

Nov 14, 2022

BUY
$14.67 - $21.7 $1.33 Million - $1.97 Million
90,738 Added 3.9%
2,417,456 $38.5 Million
Q2 2022

Aug 11, 2022

BUY
$13.46 - $48.16 $4.17 Million - $14.9 Million
309,559 Added 15.35%
2,326,718 $34.6 Million
Q1 2022

May 13, 2022

BUY
$34.22 - $47.24 $49.8 Million - $68.8 Million
1,456,553 Added 259.82%
2,017,159 $91.6 Million
Q4 2021

Feb 10, 2022

BUY
$43.29 - $58.77 $4.48 Million - $6.09 Million
103,546 Added 22.65%
560,606 $25.8 Million
Q2 2021

Aug 12, 2021

BUY
$41.49 - $59.92 $8.35 Million - $12.1 Million
201,346 Added 78.74%
457,060 $22.8 Million
Q1 2021

May 12, 2021

BUY
$46.94 - $58.66 $3.1 Million - $3.87 Million
66,003 Added 34.79%
255,714 $13.9 Million
Q4 2020

Feb 16, 2021

BUY
$42.51 - $64.0 $4.67 Million - $7.03 Million
109,790 Added 137.37%
189,711 $10.8 Million
Q3 2020

Nov 16, 2020

BUY
$49.75 - $60.68 $3.98 Million - $4.85 Million
79,921 New
79,921 $4 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.